Tirzepatide as an Alternative to Wegovy Tirzepatide (the active ingredient in Zepbound and Mounjaro) targets both GLP-1 and GIP receptors, potentially offering superior weight loss outcomes compared to semaglutide alone in clinical studies
Both contain identical semaglutide, but Wegovy is FDA-approved, brand-name, and marketed through commercial weight loss clinics
Type 2 diabetes and insulin: dont be scared, heres what you need to know : Think you might be ready for insulin
The injection has 625 meo/L of aluminum or less
Understanding tissue-specific considerations enables protocol refinement beyond generic recommendations
TeamCare offers simple cash-pay pricing (no insurance) , direct access to your provider without middle staff, and for weight loss patients, an easy messaging portal for ongoing support